(JEPQ) JPMorgan Nasdaq Equity - Ratings and Ratios
Exchange: TO • Country: Canada • Currency: CAD • Type: Etf • ISIN: CA48129Q1072
JEPQ: Canadian Equities, Options, Cash Equivalents
JPMorgan Nasdaq Equity Premium Income Active ETF (JEPQ) is an actively managed exchange-traded fund that focuses on alternative equity strategies. It is listed on a Canadian exchange, indicating its availability to Canadian investors. The funds objective is to provide income and potentially lower volatility by leveraging Nasdaq equities.
Analyzing the funds technical indicators, we observe that its current price is $25.12, slightly below its 200-day Simple Moving Average (SMA) of $25.49, suggesting a potential resistance level. The 20-day and 50-day SMAs are $24.19 and $24.34, respectively, indicating a recent uptrend. The Average True Range (ATR) is $0.59, or 2.35% of the current price, signifying moderate daily price volatility. The 52-week high and low are $27.60 and $22.06, respectively, showing the funds price range over the past year.
From a fundamental perspective, JEPQ has Assets Under Management (AUM) of $63.83 million CAD, indicating a relatively modest size. This could be both a positive and a negative; it might limit the funds ability to diversify or invest in a wide range of assets, but it also suggests that the fund is not overly complex or difficult to manage.
Given the current technical and fundamental data, a potential forecast for JEPQ could involve a cautious outlook. If the fund continues to hover around its current price, breaking through the $25.49 resistance level could signal a potential uptrend, potentially targeting the 52-week high of $27.60. Conversely, failure to break through this resistance, coupled with a decline below the $24.19 support level, could indicate a downturn, potentially towards the $22.06 level. Investors should closely monitor the funds AUM and trading volume for signs of increasing or decreasing investor interest, as well as broader market trends affecting Nasdaq equities.
To make an informed investment decision, its crucial to consider both the technical indicators and the underlying fundamental data, as well as broader market conditions and the specific investment objectives and risk tolerance of the investor.
Additional Sources for JEPQ ETF
JEPQ ETF Overview
Market Cap in USD | 47m |
Category | Alternative Equity Focused |
IPO / Inception | 2024-09-27 |
JEPQ ETF Ratings
Growth Rating | 12.8 |
Fundamental | - |
Dividend Rating | 34.1 |
Rel. Strength | -2.81 |
Analysts | - |
Fair Price Momentum | 23.45 CAD |
Fair Price DCF | - |
JEPQ Dividends
Dividend Yield 12m | 10.69% |
Yield on Cost 5y | 11.64% |
Annual Growth 5y | -13.15% |
Payout Consistency | 100.0% |
Payout Ratio | % |
JEPQ Growth Ratios
Growth Correlation 3m | -1.3% |
Growth Correlation 12m | -14.6% |
Growth Correlation 5y | -14.6% |
CAGR 5y | 8.11% |
CAGR/Max DD 5y | 0.40 |
Sharpe Ratio 12m | 1.24 |
Alpha | -3.90 |
Beta | 0.893 |
Volatility | 10.74% |
Current Volume | 11.5k |
Average Volume 20d | 11.1k |
As of June 13, 2025, the stock is trading at CAD 24.73 with a total of 11,450 shares traded.
Over the past week, the price has changed by +0.90%, over one month by -0.23%, over three months by -0.83% and over the past year by +8.11%.
Neither. Based on ValueRay´s Analyses, JPMorgan Nasdaq Equity is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 12.75 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of JEPQ is around 23.45 CAD . This means that JEPQ is currently overvalued and has a potential downside of -5.18%.
JPMorgan Nasdaq Equity has no consensus analysts rating.
According to our own proprietary Forecast Model, JEPQ JPMorgan Nasdaq Equity will be worth about 27 in June 2026. The stock is currently trading at 24.73. This means that the stock has a potential upside of +8.98%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 27 | 9% |